Citral, a component of lemongrass oil, activates PPAR α and γ and suppresses COX-2 expression

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 11, 2010, Pages 1214-1220

  Katsukawa, Michiko ^a   Nakata, Rieko ^a   Takizawa, Yoshie ^a   Hori, Kazuyuki ^b   Takahashi, Saori ^b   Inoue, Hiroyasu ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

^b Akita Research Institute of Food and Brewing   (Japan)

Author keywords

Citral; COX 2; Lemongrass; Lifestyle related disease; PPAR

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; CITRAL; CYCLOOXYGENASE 2; ESSENTIAL OIL; FATTY ACID BINDING PROTEIN 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; CYMBOPOGON CITRATUS; ENZYME ACTIVATION; ENZYME ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANIMALS; CATTLE; CELL LINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; HUMANS; LIGANDS; MODELS, CHEMICAL; MONOTERPENES; PLANT OILS; PPAR ALPHA; PPAR GAMMA; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TERPENES; U937 CELLS;

THYMUS VULGARIS;

EID: 78449241310     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.07.004     Document Type: Article

References (42)

1. Smith W.L. Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. Trends Biochem. Sci. 2008, 33:27-37.
2. Simmons D.L., Botting R.M., Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004, 56:387-437.
3. Koki A., Khan N.K., Woerner B.M., Dannenberg A.J., Olson L., Seibert K., Edwards D., Hardy M., Isakson P., Masferrer J.L. Cyclooxygenase-2 in human pathological disease. Adv. Exp. Med. Biol. 2002, 507:177-184.
4. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107:1183-1188.
5. Williams C.S., Tsujii M., Reese J., Dey S.K., Dubois R.N. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest. 2000, 105:1589-1594.
6. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 1998, 12:1063-1073.
7. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumans N., Jennettc J.C., Mahler J.F., Kluckman K.D., Ledford A., Lee C.A., Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995, 83:473-482.
8. Grosser T., Fries S., Fitzgerald G.A. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J. Clin. Invest. 2006, 116:4-15.
9. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
10. Michalik L., Auwerx J., Berger J.P., Chatteriee V.K., Glass C.K., Gonzalez F.J., Grimaldi P.A., Kadowaki T., Lazar M.A., O'Rahilly S., Palmer C.N., Plutzky L., Reddy J.K., Spiegelman B.M., Staels B., Wahli W. International Union of Pharmacology: LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 2006, 58:726-741.
11. Sonoda J., Pei L., Evans R.M. Nuclear receptors: decoding metabolic disease. FEBS Lett. 2008, 582:2-9.
12. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995, 83:803-812.
13. Kliewer S.A., Lenhard J.M., Wilson T.M., Patel I., Morris D.C., Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995, 83:813-819.
14. Inoue H., Tanabe T., Umesono K. Feedback control of Cyclooxygenase-2 expression through PPAR gamma. J. Biol. Chem. 2000, 275:28028-28032.
15. St.Leger A.S., Cochrane A.L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979, 1:1017-1020.
16. Renaud S., Lorgeri M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339:1523-1526.
17. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 1998, 273:21875-21882.
18. Inoue H., Jiang X.F., Katayama T., Osada S., Umesono K., Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci. Lett. 2003, 352:203-206.
19. Hotta M., Nakata R., Katsukawa M., Hori K., Takahashi S., Inoue H. Carvacrol, a component of thyme oil, activates PPAR alpha and gamma, and suppresses COX-2 expression. J. Lipid Res. 2010, 51:132-139.
20. Inoue H., Nanayama T., Hara S., Yokoyama C., Tanabe T. The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells. FEBS Lett. 1994, 350:51-54.
21. Inoue H., Taba Y., Miwa Y., Yokota C., Miyagi M., Sasaguri T. Transcriptional and posttranscriptional regulation of cyclooxygenase-2 expression by fluid shear stress in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1415-1420.
22. Inoue H., Tanabe T. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem. Biophys. Res. Commun. 1998, 244:143-148.
23. Nishimori T., Inoue H., Hirata Y. Involvement of the 3'-untraslated region of cyclooxygenase-2 gene in its post-transcriptional regulation through the glucocorticoid receptor. Life Sci. 2004, 74:2505-2513.
24. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 1992, 358:771-774.
25. Mueller M., Jungbauer A. Culinary plants, herbs and spices-a rich source of PPARγ ligands. Food Chem. 2009, 117:660-667.
26. Inoue H., Yokoyama C., Hara S., Tone Y., Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem. 1995, 270:24965-24971.
27. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 1995, 270:12953-12956.
28. de la Lastra C.A., Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 2005, 45:405-430.
29. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
30. Yamamoto K., Wang J., Yamamoto S., Tobe H. Suppression of cyclooxygenase-2 gene transcription by humulon of beer hop extract studied with reference to glucocorticoid. FEBS Lett. 2000, 465:103-106.
31. Yajima H., Ikeshima E., Shiraki M., Kanaya T., Fujiwara D., Odai H., Tsuboyama-Kasaoka N., Ezaki O., Oikawa S., Kondo K. Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance. J. Biol. Chem. 2004, 279:33456-33462.
32. Lianq Y.C., Tsai S.H., Tsai D.C., Lin-Shiau S.Y., Lin J.K. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett. 2001, 496:12-18.
33. Lin C.T., Chen C.J., Lin T.Y., Tung J.C., Wang S.Y. Anti-inflammation activity of fruit essential oil from Cinnamomum insularimontanum Hayata. Bioresour. Technol. 2008, 99:8783-8787.
34. Shiraki T., Kamiya N., Kodama T.S., Kakizuka A., Jingami H. alpha, beta-Unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2005, 280:14145-14153.
35. 2 to PPAR gamma. Biochem. Biophys. Res. Commun. 2005, 337:521-525.
36. Sforcin J.M., Amaral J.T., Fernandes A., Sousa J.P., Bastos J.K. Lemongrass effects on IL-1 beta and IL-6 production by macrophages. Nat. Prod. Res. 2009, 23:1151-1159.
37. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
38. Lee H.J., Jeong H.S., Kim D.J., Noh Y.H., Yuk D.Y., Hong J.T. Inhibitory effect of citral on NO production by suppression of iNOS expression and NF-kappa B activation in Raw264.7 cells. Arch. Pharm. Res. 2008, 31:342-349.
39. Sharma P.R., Mondhe D.M., Muthiah S., Pai H.C., Shahi A.K., Saxena A.K., Qazi G.N. Anticancer activity of an essential oil from Cymbopogon flexuosus. Chem. Biol. Interact. 2009, 179:160-168.
40. Stotz S.C., Vriens J., Martyn D., Clardy J., Clapham D.E. Citral sensing by transient receptor potential channels in dorsal root ganglion neurons. PLoS ONE 2008, 3:e2082.
41. Chaouki W., Leger D.Y., Liagre B., Beneytout J.L., Hmamouchi M. Citral inhibits cell proliferation and induces apoptosis and cycle arrest in MCF-7 cells. Fundam. Clin. Pharmacol. 2009, 23:549-556.
42. Mckemy D.D., Neuhausser W.M., Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002, 416:52-58.